𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)

✍ Scribed by Syme, R; Stewart, D; Rodriguez-Galvez, M; Luider, J; Auer, Y; Klassen, J; Morris, D; Brown, C; Russell, J; Glück, S

Book ID
110013812
Publisher
Nature Publishing Group
Year
2003
Tongue
English
Weight
126 KB
Volume
32
Category
Article
ISSN
0007-1188

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P53 is the strongest predictor of surviv
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support
✍ Manfred Hensel; Andreas Schneeweiss; Hans-Peter Sinn; Gerlinde Egerer; Erich Sol 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 129 KB 👁 3 views

## Abstract Our purpose was to determine the predictive value of tumor biologic parameters in patients with HRPBC who received HDCT with ASCT as first‐line treatment. From September 1992 to May 2000, 149 stage II or III HRPBC patients were enrolled in a single‐arm trial using a tandem HDCT regimen